Certain Ophthalmic Products: Policy Regarding Compliance With 21 CFR Part 4 Guidance for Industry: Guidance for Industry
Information
Type
Guidance
Regulated products
Biologics, Drugs, Medical Devices
Topics
Combination Products
Published
March 22, 2022
Last updated
March 22, 2022
Description
This document is a guidance for the industry on compliance with 21 CFR Part 4 for certain ophthalmic products, focusing on combination products.
Tags
Organization
Country / Region
United States
License
Other (Public Domain)